Title |
Management of diabetes mellitus in patients with chronic kidney disease
|
---|---|
Published in |
Clinical Diabetes and Endocrinology, June 2015
|
DOI | 10.1186/s40842-015-0001-9 |
Pubmed ID | |
Authors |
Allison J. Hahr, Mark E. Molitch |
Abstract |
Glycemic control is essential to delay or prevent the onset of diabetic kidney disease. There are a number of glucose-lowering medications available but only a fraction of them can be used safely in chronic kidney disease and many of them need an adjustment in dosing. The ideal target hemoglobin A1c is approximately 7 % but this target is adjusted based on the needs of the patient. Diabetes control should be optimized for each individual patient, with measures to reduce diabetes-related complications and minimize adverse events. Overall care of diabetes necessitates attention to multiple aspects, including reducing the risk of cardiovascular disease, and often, multidisciplinary care is needed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 20% |
Saudi Arabia | 1 | 20% |
United Kingdom | 1 | 20% |
United States | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | <1% |
Unknown | 346 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 66 | 19% |
Student > Master | 62 | 18% |
Student > Postgraduate | 35 | 10% |
Other | 20 | 6% |
Researcher | 19 | 5% |
Other | 46 | 13% |
Unknown | 99 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 103 | 30% |
Pharmacology, Toxicology and Pharmaceutical Science | 61 | 18% |
Nursing and Health Professions | 27 | 8% |
Biochemistry, Genetics and Molecular Biology | 19 | 5% |
Agricultural and Biological Sciences | 12 | 3% |
Other | 23 | 7% |
Unknown | 102 | 29% |